Singapore, March 22 -- Taliaz, an Artificial Intelligence (AI) health-analytics startup based in Israel, and Psychiatry UK LLP (PUK), the UK's online psychiatry service, announced that they have launched a groundbreaking online service to deliver AI-driven genetic testing to depression sufferers. The online medically-managed Predictix service aims to reduce patient suffering by helping psychiatrists better identify the right antidepressant medication earlier.

Dr. Dekel Taliaz, Taliaz CEO said, "With depression the world's number 1 health burden according to the World Health Organization, the online Predictix service empowers psychiatrists to better tackle the often long and painful trial and error process that today's patients face to fi...